In a latest study, we reported the identification plus the characterization of a new atypical opioid receptor with exclusive adverse regulatory Homes in direction of opioid peptides.1 Our results confirmed that ACKR3/CXCR7, hitherto generally known as an atypical scavenger receptor for chemokine